Chemours, DuPont and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam...
Covered in this story
What has happened since
- Corteva is up 1.8% since this was published, 40 days ago.
- DuPont is up 4.4% since this was published, 40 days ago.
- Chemours is down 13.9% since this was published, 40 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Corteva
- RBC Capital Markets: $14.4 → $17 by Oct 2027 · Outperform via Investing.com
- Oppenheimer: $14.4 → $17 by Oct 2027 · Outperform via Investing.com
- Goldman Sachs: $14.4 → $20 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CTVA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Corteva →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.